Pharmacokinetics (PK) and safety of enzalutamide in healthy Chinese males.

e14073Background: Enzalutamide (ENZ), an androgen receptor inhibitor, is approved in over 60 countries except China for use in metastatic castration-resistant prostate cancer. The PK of ENZ have be...